First Trust Advisors LP Solid Biosciences Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.38 - $3.77 $366,565 - $580,651	-154,019 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.49 - $5.51 $218,432 - $344,859	62,588 Added 68.45%	154,019 $564,000
Q1 2021 May 14, 2021	BUY	$5.37 - $10.72 $35,479 - $70,827	6,607 Added 7.79%	91,431 $506,000
Q4 2020 Feb 02, 2021	BUY	$3.08 - $7.79 $53,000 - $134,050	17,208 Added 25.45%	84,824 $643,000
Q3 2020 Nov 05, 2020	BUY	$2.02 - $3.08 $136,584 - $208,257	67,616 New	67,616 $137,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.